THERAPY DOSSIER · th-fc2943ece752

Artemisia campestris aqueous extract

Nutraceutical

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Other
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 0

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

No linked human trial in this dataset.

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 29306510 ↗2018Reported benefit

Protective effects of Artemisia campestris extract against gastric acid reflux-induced esophageal mucosa injuries.

RatOtherOral (per os)100, 200 and 400 mg/kg body weight

Model: Gastro-oesophageal reflux-induced oesophagitis produced by ligation of the pylorus and of the junction between the forestomach and the corpus

The aqueous extract dose-dependently reduced macroscopic and histological oesophageal injury and lipid peroxidation, and restored antioxidant enzyme activities and intracellular mediator levels.

Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.

Loading the evidence…